The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
PAAB Forum Quarterly Review, eFiles Tag and CEI Report Q4/2024
-
Good Morning @Manufacturer and @Agency
Hope everyone is staying warm and enjoying the
️.The PAAB Quarterly Tag and CEI Reports have been updated to contain data for Q4. See the Tag report here and the CEI report here.
The Forum Quarterly Review for Q4 has also been posted.
These wrap up 2024! Thank you for another great year of collaboration and compliance. We hope to continue working with you in 2025
Thank you
PAAB
